These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23411070)

  • 1. [Correlation between age and overactive bladder symptoms in young women in Brazil].
    Palma T; Raimondi M; Souto S; Fozzatti C; Palma P; Riccetto C
    Actas Urol Esp; 2013 Mar; 37(3):156-61. PubMed ID: 23411070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of prevalence of overactive bladder symptoms and child-bearing in women of reproductive age.
    Palma T; Raimondi M; Souto S; Fozzatti C; Palma P; Riccetto C
    J Obstet Gynaecol Res; 2013 Aug; 39(8):1324-9. PubMed ID: 23799891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between body mass index and overactive bladder symptoms in pre-menopausal women.
    Palma T; Raimondi M; Souto S; Fozzatti C; Palma P; Riccetto C
    Rev Assoc Med Bras (1992); 2014; 60(2):111-7. PubMed ID: 24918997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating patients' symptoms of overactive bladder by questionnaire: the role of urgency in urinary frequency.
    Mitchell SA; Brucker BM; Kaefer D; Aponte M; Rosenblum N; Kelly C; Hickling D; Nitti VW
    Urology; 2014 Nov; 84(5):1039-43. PubMed ID: 25443897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis.
    Hung MJ; Ho ES; Shen PS; Sun MJ; Lin AT; Chen GD;
    J Urol; 2006 Aug; 176(2):636-40. PubMed ID: 16813910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
    DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
    Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overactive bladder symptoms, stress urinary incontinence and associated bother in women aged 40 and above; a Belgian epidemiological survey.
    de Ridder D; Roumeguère T; Kaufman L
    Int J Clin Pract; 2013 Mar; 67(3):198-204. PubMed ID: 23409688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
    Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
    BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?
    Giarenis I; Mastoroudes H; Srikrishna S; Robinson D; Cardozo L
    BJU Int; 2013 Aug; 112(4):501-7. PubMed ID: 23452071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
    Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
    Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.
    Milsom I; Kaplan SA; Coyne KS; Sexton CC; Kopp ZS
    Urology; 2012 Jul; 80(1):90-6. PubMed ID: 22748867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women.
    Teleman PM; Lidfeldt J; Nerbrand C; Samsioe G; Mattiasson A;
    BJOG; 2004 Jun; 111(6):600-4. PubMed ID: 15198789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe depression and anxiety in women with overactive bladder.
    Melotti IGR; Juliato CRT; Tanaka M; Riccetto CLZ
    Neurourol Urodyn; 2018 Jan; 37(1):223-228. PubMed ID: 28407347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound measurement of bladder wall thickness is associated with the overactive bladder syndrome.
    Panayi DC; Tekkis P; Fernando R; Hendricken C; Khullar V
    Neurourol Urodyn; 2010 Sep; 29(7):1295-8. PubMed ID: 20127835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.